Global Topical NSAIDs Market Growth (Status and Outlook) 2026-2032
The global Topical NSAIDs market size is predicted to grow from US$ 3015 million in 2025 to US$ 4354 million in 2032; it is expected to grow at a CAGR of 5.4% from 2026 to 2032.
Topical NSAIDs (Topical Non-Steroidal Anti-Inflammatory Drugs) are pharmaceutical products containing active ingredients such as diclofenac, ibuprofen, ketoprofen, loxoprofen, flurbiprofen, felbinac, indomethacin or etofenamate. They are applied to intact skin in the form of gels, emulgels, creams, solutions, sprays, medicated patches, plasters or hydrogel poultices to relieve localized pain, inflammation, swelling and impaired mobility. Their pharmacological action is primarily associated with the inhibition of cyclooxygenase activity and prostaglandin synthesis, enabling therapeutically relevant drug concentrations to be delivered near the affected tissues. These products are mainly used for osteoarthritis, sprains, strains, contusions, tendinitis and other localized musculoskeletal pain conditions. Compared with oral formulations, topical administration generally produces lower systemic drug exposure, although NSAID-related contraindications, dosage limitations and safety warnings remain applicable.
On a manufacturer-revenue basis, the estimated gross margin of topical NSAIDs generally ranges from 45% to 70%. Standard generic gels and creams sold in highly competitive markets may generate gross margins of approximately 35%–50%, while established branded over-the-counter products can typically achieve 55%–75%. Advanced patches and plasters incorporating proprietary adhesives, controlled-release matrices, hydrogel systems or sophisticated transdermal delivery technologies may reach 60%–80% when supported by regulatory barriers, intellectual property and strong channel positioning. These ranges are analytical estimates rather than figures disclosed by any single company, and actual margins vary according to API integration, production scale, reimbursement, geographic mix, retail fees and marketing expenditure. The upstream chain comprises NSAID active ingredients, penetration enhancers, gel bases, emulsifiers, pressure-sensitive adhesives, nonwoven fabrics, backing films, release liners and pharmaceutical packaging. Midstream activities include formulation development, permeation control, mixing and filling, coating and lamination, die cutting, stability testing, clinical or bioequivalence studies and regulatory registration. Downstream channels include hospital pharmacies, retail drugstores, independent pharmacies, online pharmacies and authorized over-the-counter retail outlets. Value creation is increasingly concentrated among companies with formulation expertise, clinical evidence, established brands and extensive distribution, while digital commerce and omnichannel capabilities are becoming more important to market access.
Market Development Opportunities and Main Driving Factors
Population ageing, increasing obesity, occupational overuse and sports-related injuries are expanding the addressable population for osteoarthritis and localized musculoskeletal pain. The World Health Organization expects the prevalence and burden of osteoarthritis to rise as populations age and rates of obesity and injury increase, while clinical guidance has positioned topical NSAIDs as an important pharmacological option for knee osteoarthritis. Their localized delivery, convenient administration and relatively lower systemic exposure make them particularly relevant to older adults, patients with chronic comorbidities and consumers seeking self-care solutions. Prescription-to-OTC switches have also broadened consumer access and increased the importance of pharmacist recommendation and retail availability. As a result, topical NSAIDs are evolving beyond conventional pain-relief products into broader platforms for chronic joint management, sports medicine and everyday pain care.
Market Challenges, Risks and Restraints
The market faces growing pressure from generic competition, limited differentiation between active ingredients, retail price competition and pharmaceutical cost-containment policies. Companies relying primarily on conventional gels or standard plasters may find it increasingly difficult to sustain premium pricing without meaningful formulation, delivery or branding advantages. Topical administration does not eliminate safety concerns: products may cause local irritation, contact dermatitis, photosensitivity or allergic reactions, while application over large areas, prolonged use or concurrent administration with other NSAIDs can increase risk. Regulatory action concerning the photoallergic potential of topical ketoprofen illustrates how safety labeling, patient education and pharmacovigilance requirements can directly affect prescription status and commercial access. Differences between countries in prescription classification, approved indications, advertising rules and online pharmacy regulation also create substantial registration, compliance and channel-management costs.
Downstream Demand Trends
Future demand will increasingly combine long-term management of chronic joint conditions with immediate treatment of acute injuries. Hospitals and clinics will continue to serve patients with diagnosed osteoarthritis, tendinitis and more complex pain conditions, while retail and online pharmacies will capture a larger share of mild-to-moderate pain, sports injuries and repeat purchases. Consumer expectations are expanding beyond basic analgesic efficacy to include rapid absorption, extended adhesion, skin comfort, minimal odor, portability and reduced application frequency. High-strength gels, quick-drying sprays, extended-wear patches, flexible hydrogel poultices and packaging designed for accurate dosing are therefore likely to gain greater commercial relevance. As self-care becomes more established, purchasing decisions will increasingly be influenced by brand credibility, pharmacist advice, professional endorsement and digital health content. Retail pharmacy expansion and pharmaceutical e-commerce penetration in emerging markets will further accelerate the transition of topical NSAIDs from predominantly offline medicines into omnichannel consumer healthcare products.
Report Scope
LPI (LP Information)' newest research report, the “Topical NSAIDs Industry Forecast” looks at past sales and reviews total world Topical NSAIDs sales in 2025, providing a comprehensive analysis by region and market sector of projected Topical NSAIDs sales for 2026 through 2032. With Topical NSAIDs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topical NSAIDs industry.
This Insight Report provides a comprehensive analysis of the global Topical NSAIDs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Topical NSAIDs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Topical NSAIDs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topical NSAIDs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topical NSAIDs.
This report presents a comprehensive overview, market shares, and growth opportunities of Topical NSAIDs market by product type, application, key players and key regions and countries.
Topical NSAIDs (Topical Non-Steroidal Anti-Inflammatory Drugs) are pharmaceutical products containing active ingredients such as diclofenac, ibuprofen, ketoprofen, loxoprofen, flurbiprofen, felbinac, indomethacin or etofenamate. They are applied to intact skin in the form of gels, emulgels, creams, solutions, sprays, medicated patches, plasters or hydrogel poultices to relieve localized pain, inflammation, swelling and impaired mobility. Their pharmacological action is primarily associated with the inhibition of cyclooxygenase activity and prostaglandin synthesis, enabling therapeutically relevant drug concentrations to be delivered near the affected tissues. These products are mainly used for osteoarthritis, sprains, strains, contusions, tendinitis and other localized musculoskeletal pain conditions. Compared with oral formulations, topical administration generally produces lower systemic drug exposure, although NSAID-related contraindications, dosage limitations and safety warnings remain applicable.
On a manufacturer-revenue basis, the estimated gross margin of topical NSAIDs generally ranges from 45% to 70%. Standard generic gels and creams sold in highly competitive markets may generate gross margins of approximately 35%–50%, while established branded over-the-counter products can typically achieve 55%–75%. Advanced patches and plasters incorporating proprietary adhesives, controlled-release matrices, hydrogel systems or sophisticated transdermal delivery technologies may reach 60%–80% when supported by regulatory barriers, intellectual property and strong channel positioning. These ranges are analytical estimates rather than figures disclosed by any single company, and actual margins vary according to API integration, production scale, reimbursement, geographic mix, retail fees and marketing expenditure. The upstream chain comprises NSAID active ingredients, penetration enhancers, gel bases, emulsifiers, pressure-sensitive adhesives, nonwoven fabrics, backing films, release liners and pharmaceutical packaging. Midstream activities include formulation development, permeation control, mixing and filling, coating and lamination, die cutting, stability testing, clinical or bioequivalence studies and regulatory registration. Downstream channels include hospital pharmacies, retail drugstores, independent pharmacies, online pharmacies and authorized over-the-counter retail outlets. Value creation is increasingly concentrated among companies with formulation expertise, clinical evidence, established brands and extensive distribution, while digital commerce and omnichannel capabilities are becoming more important to market access.
Market Development Opportunities and Main Driving Factors
Population ageing, increasing obesity, occupational overuse and sports-related injuries are expanding the addressable population for osteoarthritis and localized musculoskeletal pain. The World Health Organization expects the prevalence and burden of osteoarthritis to rise as populations age and rates of obesity and injury increase, while clinical guidance has positioned topical NSAIDs as an important pharmacological option for knee osteoarthritis. Their localized delivery, convenient administration and relatively lower systemic exposure make them particularly relevant to older adults, patients with chronic comorbidities and consumers seeking self-care solutions. Prescription-to-OTC switches have also broadened consumer access and increased the importance of pharmacist recommendation and retail availability. As a result, topical NSAIDs are evolving beyond conventional pain-relief products into broader platforms for chronic joint management, sports medicine and everyday pain care.
Market Challenges, Risks and Restraints
The market faces growing pressure from generic competition, limited differentiation between active ingredients, retail price competition and pharmaceutical cost-containment policies. Companies relying primarily on conventional gels or standard plasters may find it increasingly difficult to sustain premium pricing without meaningful formulation, delivery or branding advantages. Topical administration does not eliminate safety concerns: products may cause local irritation, contact dermatitis, photosensitivity or allergic reactions, while application over large areas, prolonged use or concurrent administration with other NSAIDs can increase risk. Regulatory action concerning the photoallergic potential of topical ketoprofen illustrates how safety labeling, patient education and pharmacovigilance requirements can directly affect prescription status and commercial access. Differences between countries in prescription classification, approved indications, advertising rules and online pharmacy regulation also create substantial registration, compliance and channel-management costs.
Downstream Demand Trends
Future demand will increasingly combine long-term management of chronic joint conditions with immediate treatment of acute injuries. Hospitals and clinics will continue to serve patients with diagnosed osteoarthritis, tendinitis and more complex pain conditions, while retail and online pharmacies will capture a larger share of mild-to-moderate pain, sports injuries and repeat purchases. Consumer expectations are expanding beyond basic analgesic efficacy to include rapid absorption, extended adhesion, skin comfort, minimal odor, portability and reduced application frequency. High-strength gels, quick-drying sprays, extended-wear patches, flexible hydrogel poultices and packaging designed for accurate dosing are therefore likely to gain greater commercial relevance. As self-care becomes more established, purchasing decisions will increasingly be influenced by brand credibility, pharmacist advice, professional endorsement and digital health content. Retail pharmacy expansion and pharmaceutical e-commerce penetration in emerging markets will further accelerate the transition of topical NSAIDs from predominantly offline medicines into omnichannel consumer healthcare products.
Report Scope
LPI (LP Information)' newest research report, the “Topical NSAIDs Industry Forecast” looks at past sales and reviews total world Topical NSAIDs sales in 2025, providing a comprehensive analysis by region and market sector of projected Topical NSAIDs sales for 2026 through 2032. With Topical NSAIDs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topical NSAIDs industry.
This Insight Report provides a comprehensive analysis of the global Topical NSAIDs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Topical NSAIDs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Topical NSAIDs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topical NSAIDs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topical NSAIDs.
This report presents a comprehensive overview, market shares, and growth opportunities of Topical NSAIDs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Topical Gel
- Transdermal Patch
- Topical Cream/Ointment
- Others
Segmentation by Active Pharmaceutical Ingredient:
- Diclofenac-based
- Ibuprofen-based
- Ketoprofen-based
- Loxoprofen-based
- Flurbiprofen-based
- Others
Segmentation by Prescription Status:
- Prescription Topical NSAIDs
- Over-the-Counter Topical NSAIDs
Segmentation by Sales Channels:
- Hospital and Institutional Pharmacies
- Retail Pharmacies and Drugstores
- Online Pharmacies
- Others
Segmentation by Application:
- Osteoarthritis Pain
- Back & Muscle Pain
- Sports Injury
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Haleon
- IBSA Pharma
- Hisamitsu Pharmaceutical
- Daiichi Sankyo
- Taisho Pharmaceutical
- Perrigo
- Viatris
- Teva Pharmaceutical
- Sun Pharmaceutical
- Cipla
- Mikasa Seiyaku
- Kowa
- Dr. Reddy’s Laboratories
- Taro Pharmaceutical
- Nichiban
- Yuhan Corporation
- Dong-A Socio Holdings
- Almirall
- Searchlight Pharma
- Teikoku Pharma
- Hunan Jiudian Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Topical NSAIDs Market Size (2021-2032)
2.1.2 Topical NSAIDs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Topical NSAIDs by Country/Region (2021, 2025 & 2032)
2.2 Topical NSAIDs Segment by Type
2.2.1 Topical Gel
2.2.2 Transdermal Patch
2.2.3 Topical Cream/Ointment
2.2.4 Others
2.2.5 Topical NSAIDs Market Size by Type
2.2.5.1 Topical NSAIDs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Topical NSAIDs Market Size Market Share by Type (2021-2026)
2.3 Topical NSAIDs Segment by Active Pharmaceutical Ingredient
2.3.1 Diclofenac-based
2.3.2 Ibuprofen-based
2.3.3 Ketoprofen-based
2.3.4 Loxoprofen-based
2.3.5 Flurbiprofen-based
2.3.6 Others
2.3.7 Topical NSAIDs Market Size by Active Pharmaceutical Ingredient
2.3.7.1 Topical NSAIDs Market Size CAGR by Active Pharmaceutical Ingredient (2021 VS 2025 VS 2032)
2.3.7.2 Global Topical NSAIDs Market Size Market Share by Active Pharmaceutical Ingredient (2021-2026)
2.4 Topical NSAIDs Segment by Prescription Status
2.4.1 Prescription Topical NSAIDs
2.4.2 Over-the-Counter Topical NSAIDs
2.4.3 Topical NSAIDs Market Size by Prescription Status
2.4.3.1 Topical NSAIDs Market Size CAGR by Prescription Status (2021 VS 2025 VS 2032)
2.4.3.2 Global Topical NSAIDs Market Size Market Share by Prescription Status (2021-2026)
2.5 Topical NSAIDs Segment by Sales Channels
2.5.1 Hospital and Institutional Pharmacies
2.5.2 Retail Pharmacies and Drugstores
2.5.3 Online Pharmacies
2.5.4 Others
2.5.5 Topical NSAIDs Market Size by Sales Channels
2.5.5.1 Topical NSAIDs Market Size CAGR by Sales Channels (2021 VS 2025 VS 2032)
2.5.5.2 Global Topical NSAIDs Market Size Market Share by Sales Channels (2021-2026)
2.6 Topical NSAIDs Segment by Application
2.6.1 Osteoarthritis Pain
2.6.2 Back & Muscle Pain
2.6.3 Sports Injury
2.6.4 Others
2.6.5 Topical NSAIDs Market Size by Application
2.6.5.1 Topical NSAIDs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.6.5.2 Global Topical NSAIDs Market Size Market Share by Application (2021-2026)
3 TOPICAL NSAIDS MARKET SIZE BY PLAYER
3.1 Topical NSAIDs Market Size Market Share by Player
3.1.1 Global Topical NSAIDs Revenue by Player (2021-2026)
3.1.2 Global Topical NSAIDs Revenue Market Share by Player (2021-2026)
3.2 Global Topical NSAIDs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TOPICAL NSAIDS BY REGION
4.1 Topical NSAIDs Market Size by Region (2021-2026)
4.2 Global Topical NSAIDs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Topical NSAIDs Market Size Growth (2021-2026)
4.4 APAC Topical NSAIDs Market Size Growth (2021-2026)
4.5 Europe Topical NSAIDs Market Size Growth (2021-2026)
4.6 Middle East & Africa Topical NSAIDs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Topical NSAIDs Market Size by Country (2021-2026)
5.2 Americas Topical NSAIDs Market Size by Type (2021-2026)
5.3 Americas Topical NSAIDs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Topical NSAIDs Market Size by Region (2021-2026)
6.2 APAC Topical NSAIDs Market Size by Type (2021-2026)
6.3 APAC Topical NSAIDs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Topical NSAIDs Market Size by Country (2021-2026)
7.2 Europe Topical NSAIDs Market Size by Type (2021-2026)
7.3 Europe Topical NSAIDs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Topical NSAIDs by Region (2021-2026)
8.2 Middle East & Africa Topical NSAIDs Market Size by Type (2021-2026)
8.3 Middle East & Africa Topical NSAIDs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TOPICAL NSAIDS MARKET FORECAST
10.1 Global Topical NSAIDs Forecast by Region (2027-2032)
10.1.1 Global Topical NSAIDs Forecast by Region (2027-2032)
10.1.2 Americas Topical NSAIDs Forecast
10.1.3 APAC Topical NSAIDs Forecast
10.1.4 Europe Topical NSAIDs Forecast
10.1.5 Middle East & Africa Topical NSAIDs Forecast
10.2 Americas Topical NSAIDs Forecast by Country (2027-2032)
10.2.1 United States Market Topical NSAIDs Forecast
10.2.2 Canada Market Topical NSAIDs Forecast
10.2.3 Mexico Market Topical NSAIDs Forecast
10.2.4 Brazil Market Topical NSAIDs Forecast
10.3 APAC Topical NSAIDs Forecast by Region (2027-2032)
10.3.1 China Topical NSAIDs Market Forecast
10.3.2 Japan Market Topical NSAIDs Forecast
10.3.3 Korea Market Topical NSAIDs Forecast
10.3.4 Southeast Asia Market Topical NSAIDs Forecast
10.3.5 India Market Topical NSAIDs Forecast
10.3.6 Australia Market Topical NSAIDs Forecast
10.4 Europe Topical NSAIDs Forecast by Country (2027-2032)
10.4.1 Germany Market Topical NSAIDs Forecast
10.4.2 France Market Topical NSAIDs Forecast
10.4.3 UK Market Topical NSAIDs Forecast
10.4.4 Italy Market Topical NSAIDs Forecast
10.4.5 Russia Market Topical NSAIDs Forecast
10.5 Middle East & Africa Topical NSAIDs Forecast by Region (2027-2032)
10.5.1 Egypt Market Topical NSAIDs Forecast
10.5.2 South Africa Market Topical NSAIDs Forecast
10.5.3 Israel Market Topical NSAIDs Forecast
10.5.4 Turkey Market Topical NSAIDs Forecast
10.6 Global Topical NSAIDs Forecast by Type (2027-2032)
10.7 Global Topical NSAIDs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Topical NSAIDs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Haleon
11.1.1 Haleon Company Information
11.1.2 Haleon Topical NSAIDs Product Offered
11.1.3 Haleon Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Haleon Main Business Overview
11.1.5 Haleon Latest Developments
11.2 IBSA Pharma
11.2.1 IBSA Pharma Company Information
11.2.2 IBSA Pharma Topical NSAIDs Product Offered
11.2.3 IBSA Pharma Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 IBSA Pharma Main Business Overview
11.2.5 IBSA Pharma Latest Developments
11.3 Hisamitsu Pharmaceutical
11.3.1 Hisamitsu Pharmaceutical Company Information
11.3.2 Hisamitsu Pharmaceutical Topical NSAIDs Product Offered
11.3.3 Hisamitsu Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Hisamitsu Pharmaceutical Main Business Overview
11.3.5 Hisamitsu Pharmaceutical Latest Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Information
11.4.2 Daiichi Sankyo Topical NSAIDs Product Offered
11.4.3 Daiichi Sankyo Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Daiichi Sankyo Main Business Overview
11.4.5 Daiichi Sankyo Latest Developments
11.5 Taisho Pharmaceutical
11.5.1 Taisho Pharmaceutical Company Information
11.5.2 Taisho Pharmaceutical Topical NSAIDs Product Offered
11.5.3 Taisho Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Taisho Pharmaceutical Main Business Overview
11.5.5 Taisho Pharmaceutical Latest Developments
11.6 Perrigo
11.6.1 Perrigo Company Information
11.6.2 Perrigo Topical NSAIDs Product Offered
11.6.3 Perrigo Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Perrigo Main Business Overview
11.6.5 Perrigo Latest Developments
11.7 Viatris
11.7.1 Viatris Company Information
11.7.2 Viatris Topical NSAIDs Product Offered
11.7.3 Viatris Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Viatris Main Business Overview
11.7.5 Viatris Latest Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Information
11.8.2 Teva Pharmaceutical Topical NSAIDs Product Offered
11.8.3 Teva Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Teva Pharmaceutical Main Business Overview
11.8.5 Teva Pharmaceutical Latest Developments
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Information
11.9.2 Sun Pharmaceutical Topical NSAIDs Product Offered
11.9.3 Sun Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sun Pharmaceutical Main Business Overview
11.9.5 Sun Pharmaceutical Latest Developments
11.10 Cipla
11.10.1 Cipla Company Information
11.10.2 Cipla Topical NSAIDs Product Offered
11.10.3 Cipla Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Cipla Main Business Overview
11.10.5 Cipla Latest Developments
11.11 Mikasa Seiyaku
11.11.1 Mikasa Seiyaku Company Information
11.11.2 Mikasa Seiyaku Topical NSAIDs Product Offered
11.11.3 Mikasa Seiyaku Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Mikasa Seiyaku Main Business Overview
11.11.5 Mikasa Seiyaku Latest Developments
11.12 Kowa
11.12.1 Kowa Company Information
11.12.2 Kowa Topical NSAIDs Product Offered
11.12.3 Kowa Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Kowa Main Business Overview
11.12.5 Kowa Latest Developments
11.13 Dr. Reddy’s Laboratories
11.13.1 Dr. Reddy’s Laboratories Company Information
11.13.2 Dr. Reddy’s Laboratories Topical NSAIDs Product Offered
11.13.3 Dr. Reddy’s Laboratories Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Dr. Reddy’s Laboratories Main Business Overview
11.13.5 Dr. Reddy’s Laboratories Latest Developments
11.14 Taro Pharmaceutical
11.14.1 Taro Pharmaceutical Company Information
11.14.2 Taro Pharmaceutical Topical NSAIDs Product Offered
11.14.3 Taro Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Taro Pharmaceutical Main Business Overview
11.14.5 Taro Pharmaceutical Latest Developments
11.15 Nichiban
11.15.1 Nichiban Company Information
11.15.2 Nichiban Topical NSAIDs Product Offered
11.15.3 Nichiban Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Nichiban Main Business Overview
11.15.5 Nichiban Latest Developments
11.16 Yuhan Corporation
11.16.1 Yuhan Corporation Company Information
11.16.2 Yuhan Corporation Topical NSAIDs Product Offered
11.16.3 Yuhan Corporation Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Yuhan Corporation Main Business Overview
11.16.5 Yuhan Corporation Latest Developments
11.17 Dong-A Socio Holdings
11.17.1 Dong-A Socio Holdings Company Information
11.17.2 Dong-A Socio Holdings Topical NSAIDs Product Offered
11.17.3 Dong-A Socio Holdings Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Dong-A Socio Holdings Main Business Overview
11.17.5 Dong-A Socio Holdings Latest Developments
11.18 Almirall
11.18.1 Almirall Company Information
11.18.2 Almirall Topical NSAIDs Product Offered
11.18.3 Almirall Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Almirall Main Business Overview
11.18.5 Almirall Latest Developments
11.19 Searchlight Pharma
11.19.1 Searchlight Pharma Company Information
11.19.2 Searchlight Pharma Topical NSAIDs Product Offered
11.19.3 Searchlight Pharma Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Searchlight Pharma Main Business Overview
11.19.5 Searchlight Pharma Latest Developments
11.20 Teikoku Pharma
11.20.1 Teikoku Pharma Company Information
11.20.2 Teikoku Pharma Topical NSAIDs Product Offered
11.20.3 Teikoku Pharma Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Teikoku Pharma Main Business Overview
11.20.5 Teikoku Pharma Latest Developments
11.21 Hunan Jiudian Pharmaceutical
11.21.1 Hunan Jiudian Pharmaceutical Company Information
11.21.2 Hunan Jiudian Pharmaceutical Topical NSAIDs Product Offered
11.21.3 Hunan Jiudian Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Hunan Jiudian Pharmaceutical Main Business Overview
11.21.5 Hunan Jiudian Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Topical NSAIDs Market Size (2021-2032)
2.1.2 Topical NSAIDs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Topical NSAIDs by Country/Region (2021, 2025 & 2032)
2.2 Topical NSAIDs Segment by Type
2.2.1 Topical Gel
2.2.2 Transdermal Patch
2.2.3 Topical Cream/Ointment
2.2.4 Others
2.2.5 Topical NSAIDs Market Size by Type
2.2.5.1 Topical NSAIDs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Topical NSAIDs Market Size Market Share by Type (2021-2026)
2.3 Topical NSAIDs Segment by Active Pharmaceutical Ingredient
2.3.1 Diclofenac-based
2.3.2 Ibuprofen-based
2.3.3 Ketoprofen-based
2.3.4 Loxoprofen-based
2.3.5 Flurbiprofen-based
2.3.6 Others
2.3.7 Topical NSAIDs Market Size by Active Pharmaceutical Ingredient
2.3.7.1 Topical NSAIDs Market Size CAGR by Active Pharmaceutical Ingredient (2021 VS 2025 VS 2032)
2.3.7.2 Global Topical NSAIDs Market Size Market Share by Active Pharmaceutical Ingredient (2021-2026)
2.4 Topical NSAIDs Segment by Prescription Status
2.4.1 Prescription Topical NSAIDs
2.4.2 Over-the-Counter Topical NSAIDs
2.4.3 Topical NSAIDs Market Size by Prescription Status
2.4.3.1 Topical NSAIDs Market Size CAGR by Prescription Status (2021 VS 2025 VS 2032)
2.4.3.2 Global Topical NSAIDs Market Size Market Share by Prescription Status (2021-2026)
2.5 Topical NSAIDs Segment by Sales Channels
2.5.1 Hospital and Institutional Pharmacies
2.5.2 Retail Pharmacies and Drugstores
2.5.3 Online Pharmacies
2.5.4 Others
2.5.5 Topical NSAIDs Market Size by Sales Channels
2.5.5.1 Topical NSAIDs Market Size CAGR by Sales Channels (2021 VS 2025 VS 2032)
2.5.5.2 Global Topical NSAIDs Market Size Market Share by Sales Channels (2021-2026)
2.6 Topical NSAIDs Segment by Application
2.6.1 Osteoarthritis Pain
2.6.2 Back & Muscle Pain
2.6.3 Sports Injury
2.6.4 Others
2.6.5 Topical NSAIDs Market Size by Application
2.6.5.1 Topical NSAIDs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.6.5.2 Global Topical NSAIDs Market Size Market Share by Application (2021-2026)
3 TOPICAL NSAIDS MARKET SIZE BY PLAYER
3.1 Topical NSAIDs Market Size Market Share by Player
3.1.1 Global Topical NSAIDs Revenue by Player (2021-2026)
3.1.2 Global Topical NSAIDs Revenue Market Share by Player (2021-2026)
3.2 Global Topical NSAIDs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TOPICAL NSAIDS BY REGION
4.1 Topical NSAIDs Market Size by Region (2021-2026)
4.2 Global Topical NSAIDs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Topical NSAIDs Market Size Growth (2021-2026)
4.4 APAC Topical NSAIDs Market Size Growth (2021-2026)
4.5 Europe Topical NSAIDs Market Size Growth (2021-2026)
4.6 Middle East & Africa Topical NSAIDs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Topical NSAIDs Market Size by Country (2021-2026)
5.2 Americas Topical NSAIDs Market Size by Type (2021-2026)
5.3 Americas Topical NSAIDs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Topical NSAIDs Market Size by Region (2021-2026)
6.2 APAC Topical NSAIDs Market Size by Type (2021-2026)
6.3 APAC Topical NSAIDs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Topical NSAIDs Market Size by Country (2021-2026)
7.2 Europe Topical NSAIDs Market Size by Type (2021-2026)
7.3 Europe Topical NSAIDs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Topical NSAIDs by Region (2021-2026)
8.2 Middle East & Africa Topical NSAIDs Market Size by Type (2021-2026)
8.3 Middle East & Africa Topical NSAIDs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TOPICAL NSAIDS MARKET FORECAST
10.1 Global Topical NSAIDs Forecast by Region (2027-2032)
10.1.1 Global Topical NSAIDs Forecast by Region (2027-2032)
10.1.2 Americas Topical NSAIDs Forecast
10.1.3 APAC Topical NSAIDs Forecast
10.1.4 Europe Topical NSAIDs Forecast
10.1.5 Middle East & Africa Topical NSAIDs Forecast
10.2 Americas Topical NSAIDs Forecast by Country (2027-2032)
10.2.1 United States Market Topical NSAIDs Forecast
10.2.2 Canada Market Topical NSAIDs Forecast
10.2.3 Mexico Market Topical NSAIDs Forecast
10.2.4 Brazil Market Topical NSAIDs Forecast
10.3 APAC Topical NSAIDs Forecast by Region (2027-2032)
10.3.1 China Topical NSAIDs Market Forecast
10.3.2 Japan Market Topical NSAIDs Forecast
10.3.3 Korea Market Topical NSAIDs Forecast
10.3.4 Southeast Asia Market Topical NSAIDs Forecast
10.3.5 India Market Topical NSAIDs Forecast
10.3.6 Australia Market Topical NSAIDs Forecast
10.4 Europe Topical NSAIDs Forecast by Country (2027-2032)
10.4.1 Germany Market Topical NSAIDs Forecast
10.4.2 France Market Topical NSAIDs Forecast
10.4.3 UK Market Topical NSAIDs Forecast
10.4.4 Italy Market Topical NSAIDs Forecast
10.4.5 Russia Market Topical NSAIDs Forecast
10.5 Middle East & Africa Topical NSAIDs Forecast by Region (2027-2032)
10.5.1 Egypt Market Topical NSAIDs Forecast
10.5.2 South Africa Market Topical NSAIDs Forecast
10.5.3 Israel Market Topical NSAIDs Forecast
10.5.4 Turkey Market Topical NSAIDs Forecast
10.6 Global Topical NSAIDs Forecast by Type (2027-2032)
10.7 Global Topical NSAIDs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Topical NSAIDs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Haleon
11.1.1 Haleon Company Information
11.1.2 Haleon Topical NSAIDs Product Offered
11.1.3 Haleon Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Haleon Main Business Overview
11.1.5 Haleon Latest Developments
11.2 IBSA Pharma
11.2.1 IBSA Pharma Company Information
11.2.2 IBSA Pharma Topical NSAIDs Product Offered
11.2.3 IBSA Pharma Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 IBSA Pharma Main Business Overview
11.2.5 IBSA Pharma Latest Developments
11.3 Hisamitsu Pharmaceutical
11.3.1 Hisamitsu Pharmaceutical Company Information
11.3.2 Hisamitsu Pharmaceutical Topical NSAIDs Product Offered
11.3.3 Hisamitsu Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Hisamitsu Pharmaceutical Main Business Overview
11.3.5 Hisamitsu Pharmaceutical Latest Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Information
11.4.2 Daiichi Sankyo Topical NSAIDs Product Offered
11.4.3 Daiichi Sankyo Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Daiichi Sankyo Main Business Overview
11.4.5 Daiichi Sankyo Latest Developments
11.5 Taisho Pharmaceutical
11.5.1 Taisho Pharmaceutical Company Information
11.5.2 Taisho Pharmaceutical Topical NSAIDs Product Offered
11.5.3 Taisho Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Taisho Pharmaceutical Main Business Overview
11.5.5 Taisho Pharmaceutical Latest Developments
11.6 Perrigo
11.6.1 Perrigo Company Information
11.6.2 Perrigo Topical NSAIDs Product Offered
11.6.3 Perrigo Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Perrigo Main Business Overview
11.6.5 Perrigo Latest Developments
11.7 Viatris
11.7.1 Viatris Company Information
11.7.2 Viatris Topical NSAIDs Product Offered
11.7.3 Viatris Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Viatris Main Business Overview
11.7.5 Viatris Latest Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Information
11.8.2 Teva Pharmaceutical Topical NSAIDs Product Offered
11.8.3 Teva Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Teva Pharmaceutical Main Business Overview
11.8.5 Teva Pharmaceutical Latest Developments
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Information
11.9.2 Sun Pharmaceutical Topical NSAIDs Product Offered
11.9.3 Sun Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sun Pharmaceutical Main Business Overview
11.9.5 Sun Pharmaceutical Latest Developments
11.10 Cipla
11.10.1 Cipla Company Information
11.10.2 Cipla Topical NSAIDs Product Offered
11.10.3 Cipla Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Cipla Main Business Overview
11.10.5 Cipla Latest Developments
11.11 Mikasa Seiyaku
11.11.1 Mikasa Seiyaku Company Information
11.11.2 Mikasa Seiyaku Topical NSAIDs Product Offered
11.11.3 Mikasa Seiyaku Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Mikasa Seiyaku Main Business Overview
11.11.5 Mikasa Seiyaku Latest Developments
11.12 Kowa
11.12.1 Kowa Company Information
11.12.2 Kowa Topical NSAIDs Product Offered
11.12.3 Kowa Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Kowa Main Business Overview
11.12.5 Kowa Latest Developments
11.13 Dr. Reddy’s Laboratories
11.13.1 Dr. Reddy’s Laboratories Company Information
11.13.2 Dr. Reddy’s Laboratories Topical NSAIDs Product Offered
11.13.3 Dr. Reddy’s Laboratories Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Dr. Reddy’s Laboratories Main Business Overview
11.13.5 Dr. Reddy’s Laboratories Latest Developments
11.14 Taro Pharmaceutical
11.14.1 Taro Pharmaceutical Company Information
11.14.2 Taro Pharmaceutical Topical NSAIDs Product Offered
11.14.3 Taro Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Taro Pharmaceutical Main Business Overview
11.14.5 Taro Pharmaceutical Latest Developments
11.15 Nichiban
11.15.1 Nichiban Company Information
11.15.2 Nichiban Topical NSAIDs Product Offered
11.15.3 Nichiban Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Nichiban Main Business Overview
11.15.5 Nichiban Latest Developments
11.16 Yuhan Corporation
11.16.1 Yuhan Corporation Company Information
11.16.2 Yuhan Corporation Topical NSAIDs Product Offered
11.16.3 Yuhan Corporation Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Yuhan Corporation Main Business Overview
11.16.5 Yuhan Corporation Latest Developments
11.17 Dong-A Socio Holdings
11.17.1 Dong-A Socio Holdings Company Information
11.17.2 Dong-A Socio Holdings Topical NSAIDs Product Offered
11.17.3 Dong-A Socio Holdings Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Dong-A Socio Holdings Main Business Overview
11.17.5 Dong-A Socio Holdings Latest Developments
11.18 Almirall
11.18.1 Almirall Company Information
11.18.2 Almirall Topical NSAIDs Product Offered
11.18.3 Almirall Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Almirall Main Business Overview
11.18.5 Almirall Latest Developments
11.19 Searchlight Pharma
11.19.1 Searchlight Pharma Company Information
11.19.2 Searchlight Pharma Topical NSAIDs Product Offered
11.19.3 Searchlight Pharma Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Searchlight Pharma Main Business Overview
11.19.5 Searchlight Pharma Latest Developments
11.20 Teikoku Pharma
11.20.1 Teikoku Pharma Company Information
11.20.2 Teikoku Pharma Topical NSAIDs Product Offered
11.20.3 Teikoku Pharma Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Teikoku Pharma Main Business Overview
11.20.5 Teikoku Pharma Latest Developments
11.21 Hunan Jiudian Pharmaceutical
11.21.1 Hunan Jiudian Pharmaceutical Company Information
11.21.2 Hunan Jiudian Pharmaceutical Topical NSAIDs Product Offered
11.21.3 Hunan Jiudian Pharmaceutical Topical NSAIDs Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Hunan Jiudian Pharmaceutical Main Business Overview
11.21.5 Hunan Jiudian Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Topical NSAIDs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Topical NSAIDs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Topical Gel
Table 4. Major Players of Transdermal Patch
Table 5. Major Players of Topical Cream/Ointment
Table 6. Major Players of Others
Table 7. Topical NSAIDs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Topical NSAIDs Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Topical NSAIDs Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Diclofenac-based
Table 11. Major Players of Ibuprofen-based
Table 12. Major Players of Ketoprofen-based
Table 13. Major Players of Loxoprofen-based
Table 14. Major Players of Flurbiprofen-based
Table 15. Major Players of Others
Table 16. Topical NSAIDs Market Size CAGR by Active Pharmaceutical Ingredient (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Topical NSAIDs Market Size by Active Pharmaceutical Ingredient (2021-2026) & ($ millions)
Table 18. Global Topical NSAIDs Market Size Market Share by Active Pharmaceutical Ingredient (2021-2026)
Table 19. Major Players of Prescription Topical NSAIDs
Table 20. Major Players of Over-the-Counter Topical NSAIDs
Table 21. Topical NSAIDs Market Size CAGR by Prescription Status (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Topical NSAIDs Market Size by Prescription Status (2021-2026) & ($ millions)
Table 23. Global Topical NSAIDs Market Size Market Share by Prescription Status (2021-2026)
Table 24. Major Players of Hospital and Institutional Pharmacies
Table 25. Major Players of Retail Pharmacies and Drugstores
Table 26. Major Players of Online Pharmacies
Table 27. Major Players of Others
Table 28. Topical NSAIDs Market Size CAGR by Sales Channels (2021 VS 2025 VS 2032) & ($ millions)
Table 29. Global Topical NSAIDs Market Size by Sales Channels (2021-2026) & ($ millions)
Table 30. Global Topical NSAIDs Market Size Market Share by Sales Channels (2021-2026)
Table 31. Topical NSAIDs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 32. Global Topical NSAIDs Market Size by Application (2021-2026) & ($ millions)
Table 33. Global Topical NSAIDs Market Size Market Share by Application (2021-2026)
Table 34. Global Topical NSAIDs Revenue by Player (2021-2026) & ($ millions)
Table 35. Global Topical NSAIDs Revenue Market Share by Player (2021-2026)
Table 36. Topical NSAIDs Key Players Head office and Products Offered
Table 37. Topical NSAIDs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Mergers & Acquisitions, Expansion
Table 40. Global Topical NSAIDs Market Size by Region (2021-2026) & ($ millions)
Table 41. Global Topical NSAIDs Market Size Market Share by Region (2021-2026)
Table 42. Global Topical NSAIDs Revenue by Country/Region (2021-2026) & ($ millions)
Table 43. Global Topical NSAIDs Revenue Market Share by Country/Region (2021-2026)
Table 44. Americas Topical NSAIDs Market Size by Country (2021-2026) & ($ millions)
Table 45. Americas Topical NSAIDs Market Size Market Share by Country (2021-2026)
Table 46. Americas Topical NSAIDs Market Size by Type (2021-2026) & ($ millions)
Table 47. Americas Topical NSAIDs Market Size Market Share by Type (2021-2026)
Table 48. Americas Topical NSAIDs Market Size by Application (2021-2026) & ($ millions)
Table 49. Americas Topical NSAIDs Market Size Market Share by Application (2021-2026)
Table 50. APAC Topical NSAIDs Market Size by Region (2021-2026) & ($ millions)
Table 51. APAC Topical NSAIDs Market Size Market Share by Region (2021-2026)
Table 52. APAC Topical NSAIDs Market Size by Type (2021-2026) & ($ millions)
Table 53. APAC Topical NSAIDs Market Size by Application (2021-2026) & ($ millions)
Table 54. Europe Topical NSAIDs Market Size by Country (2021-2026) & ($ millions)
Table 55. Europe Topical NSAIDs Market Size Market Share by Country (2021-2026)
Table 56. Europe Topical NSAIDs Market Size by Type (2021-2026) & ($ millions)
Table 57. Europe Topical NSAIDs Market Size by Application (2021-2026) & ($ millions)
Table 58. Middle East & Africa Topical NSAIDs Market Size by Region (2021-2026) & ($ millions)
Table 59. Middle East & Africa Topical NSAIDs Market Size by Type (2021-2026) & ($ millions)
Table 60. Middle East & Africa Topical NSAIDs Market Size by Application (2021-2026) & ($ millions)
Table 61. Key Market Drivers & Growth Opportunities of Topical NSAIDs
Table 62. Key Market Challenges & Risks of Topical NSAIDs
Table 63. Key Industry Trends of Topical NSAIDs
Table 64. Global Topical NSAIDs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 65. Global Topical NSAIDs Market Size Market Share Forecast by Region (2027-2032)
Table 66. Global Topical NSAIDs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 67. Global Topical NSAIDs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 68. Haleon Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 69. Haleon Topical NSAIDs Product Offered
Table 70. Haleon Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Haleon Main Business
Table 72. Haleon Latest Developments
Table 73. IBSA Pharma Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 74. IBSA Pharma Topical NSAIDs Product Offered
Table 75. IBSA Pharma Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. IBSA Pharma Main Business
Table 77. IBSA Pharma Latest Developments
Table 78. Hisamitsu Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 79. Hisamitsu Pharmaceutical Topical NSAIDs Product Offered
Table 80. Hisamitsu Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Hisamitsu Pharmaceutical Main Business
Table 82. Hisamitsu Pharmaceutical Latest Developments
Table 83. Daiichi Sankyo Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 84. Daiichi Sankyo Topical NSAIDs Product Offered
Table 85. Daiichi Sankyo Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Daiichi Sankyo Main Business
Table 87. Daiichi Sankyo Latest Developments
Table 88. Taisho Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 89. Taisho Pharmaceutical Topical NSAIDs Product Offered
Table 90. Taisho Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Taisho Pharmaceutical Main Business
Table 92. Taisho Pharmaceutical Latest Developments
Table 93. Perrigo Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 94. Perrigo Topical NSAIDs Product Offered
Table 95. Perrigo Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Perrigo Main Business
Table 97. Perrigo Latest Developments
Table 98. Viatris Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 99. Viatris Topical NSAIDs Product Offered
Table 100. Viatris Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Viatris Main Business
Table 102. Viatris Latest Developments
Table 103. Teva Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 104. Teva Pharmaceutical Topical NSAIDs Product Offered
Table 105. Teva Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Teva Pharmaceutical Main Business
Table 107. Teva Pharmaceutical Latest Developments
Table 108. Sun Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 109. Sun Pharmaceutical Topical NSAIDs Product Offered
Table 110. Sun Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Sun Pharmaceutical Main Business
Table 112. Sun Pharmaceutical Latest Developments
Table 113. Cipla Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 114. Cipla Topical NSAIDs Product Offered
Table 115. Cipla Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Cipla Main Business
Table 117. Cipla Latest Developments
Table 118. Mikasa Seiyaku Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 119. Mikasa Seiyaku Topical NSAIDs Product Offered
Table 120. Mikasa Seiyaku Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Mikasa Seiyaku Main Business
Table 122. Mikasa Seiyaku Latest Developments
Table 123. Kowa Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 124. Kowa Topical NSAIDs Product Offered
Table 125. Kowa Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Kowa Main Business
Table 127. Kowa Latest Developments
Table 128. Dr. Reddy’s Laboratories Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 129. Dr. Reddy’s Laboratories Topical NSAIDs Product Offered
Table 130. Dr. Reddy’s Laboratories Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Dr. Reddy’s Laboratories Main Business
Table 132. Dr. Reddy’s Laboratories Latest Developments
Table 133. Taro Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 134. Taro Pharmaceutical Topical NSAIDs Product Offered
Table 135. Taro Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Taro Pharmaceutical Main Business
Table 137. Taro Pharmaceutical Latest Developments
Table 138. Nichiban Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 139. Nichiban Topical NSAIDs Product Offered
Table 140. Nichiban Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Nichiban Main Business
Table 142. Nichiban Latest Developments
Table 143. Yuhan Corporation Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 144. Yuhan Corporation Topical NSAIDs Product Offered
Table 145. Yuhan Corporation Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Yuhan Corporation Main Business
Table 147. Yuhan Corporation Latest Developments
Table 148. Dong-A Socio Holdings Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 149. Dong-A Socio Holdings Topical NSAIDs Product Offered
Table 150. Dong-A Socio Holdings Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Dong-A Socio Holdings Main Business
Table 152. Dong-A Socio Holdings Latest Developments
Table 153. Almirall Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 154. Almirall Topical NSAIDs Product Offered
Table 155. Almirall Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. Almirall Main Business
Table 157. Almirall Latest Developments
Table 158. Searchlight Pharma Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 159. Searchlight Pharma Topical NSAIDs Product Offered
Table 160. Searchlight Pharma Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 161. Searchlight Pharma Main Business
Table 162. Searchlight Pharma Latest Developments
Table 163. Teikoku Pharma Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 164. Teikoku Pharma Topical NSAIDs Product Offered
Table 165. Teikoku Pharma Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 166. Teikoku Pharma Main Business
Table 167. Teikoku Pharma Latest Developments
Table 168. Hunan Jiudian Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 169. Hunan Jiudian Pharmaceutical Topical NSAIDs Product Offered
Table 170. Hunan Jiudian Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 171. Hunan Jiudian Pharmaceutical Main Business
Table 172. Hunan Jiudian Pharmaceutical Latest Developments
Table 1. Topical NSAIDs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Topical NSAIDs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Topical Gel
Table 4. Major Players of Transdermal Patch
Table 5. Major Players of Topical Cream/Ointment
Table 6. Major Players of Others
Table 7. Topical NSAIDs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Topical NSAIDs Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Topical NSAIDs Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Diclofenac-based
Table 11. Major Players of Ibuprofen-based
Table 12. Major Players of Ketoprofen-based
Table 13. Major Players of Loxoprofen-based
Table 14. Major Players of Flurbiprofen-based
Table 15. Major Players of Others
Table 16. Topical NSAIDs Market Size CAGR by Active Pharmaceutical Ingredient (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Topical NSAIDs Market Size by Active Pharmaceutical Ingredient (2021-2026) & ($ millions)
Table 18. Global Topical NSAIDs Market Size Market Share by Active Pharmaceutical Ingredient (2021-2026)
Table 19. Major Players of Prescription Topical NSAIDs
Table 20. Major Players of Over-the-Counter Topical NSAIDs
Table 21. Topical NSAIDs Market Size CAGR by Prescription Status (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Topical NSAIDs Market Size by Prescription Status (2021-2026) & ($ millions)
Table 23. Global Topical NSAIDs Market Size Market Share by Prescription Status (2021-2026)
Table 24. Major Players of Hospital and Institutional Pharmacies
Table 25. Major Players of Retail Pharmacies and Drugstores
Table 26. Major Players of Online Pharmacies
Table 27. Major Players of Others
Table 28. Topical NSAIDs Market Size CAGR by Sales Channels (2021 VS 2025 VS 2032) & ($ millions)
Table 29. Global Topical NSAIDs Market Size by Sales Channels (2021-2026) & ($ millions)
Table 30. Global Topical NSAIDs Market Size Market Share by Sales Channels (2021-2026)
Table 31. Topical NSAIDs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 32. Global Topical NSAIDs Market Size by Application (2021-2026) & ($ millions)
Table 33. Global Topical NSAIDs Market Size Market Share by Application (2021-2026)
Table 34. Global Topical NSAIDs Revenue by Player (2021-2026) & ($ millions)
Table 35. Global Topical NSAIDs Revenue Market Share by Player (2021-2026)
Table 36. Topical NSAIDs Key Players Head office and Products Offered
Table 37. Topical NSAIDs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Mergers & Acquisitions, Expansion
Table 40. Global Topical NSAIDs Market Size by Region (2021-2026) & ($ millions)
Table 41. Global Topical NSAIDs Market Size Market Share by Region (2021-2026)
Table 42. Global Topical NSAIDs Revenue by Country/Region (2021-2026) & ($ millions)
Table 43. Global Topical NSAIDs Revenue Market Share by Country/Region (2021-2026)
Table 44. Americas Topical NSAIDs Market Size by Country (2021-2026) & ($ millions)
Table 45. Americas Topical NSAIDs Market Size Market Share by Country (2021-2026)
Table 46. Americas Topical NSAIDs Market Size by Type (2021-2026) & ($ millions)
Table 47. Americas Topical NSAIDs Market Size Market Share by Type (2021-2026)
Table 48. Americas Topical NSAIDs Market Size by Application (2021-2026) & ($ millions)
Table 49. Americas Topical NSAIDs Market Size Market Share by Application (2021-2026)
Table 50. APAC Topical NSAIDs Market Size by Region (2021-2026) & ($ millions)
Table 51. APAC Topical NSAIDs Market Size Market Share by Region (2021-2026)
Table 52. APAC Topical NSAIDs Market Size by Type (2021-2026) & ($ millions)
Table 53. APAC Topical NSAIDs Market Size by Application (2021-2026) & ($ millions)
Table 54. Europe Topical NSAIDs Market Size by Country (2021-2026) & ($ millions)
Table 55. Europe Topical NSAIDs Market Size Market Share by Country (2021-2026)
Table 56. Europe Topical NSAIDs Market Size by Type (2021-2026) & ($ millions)
Table 57. Europe Topical NSAIDs Market Size by Application (2021-2026) & ($ millions)
Table 58. Middle East & Africa Topical NSAIDs Market Size by Region (2021-2026) & ($ millions)
Table 59. Middle East & Africa Topical NSAIDs Market Size by Type (2021-2026) & ($ millions)
Table 60. Middle East & Africa Topical NSAIDs Market Size by Application (2021-2026) & ($ millions)
Table 61. Key Market Drivers & Growth Opportunities of Topical NSAIDs
Table 62. Key Market Challenges & Risks of Topical NSAIDs
Table 63. Key Industry Trends of Topical NSAIDs
Table 64. Global Topical NSAIDs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 65. Global Topical NSAIDs Market Size Market Share Forecast by Region (2027-2032)
Table 66. Global Topical NSAIDs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 67. Global Topical NSAIDs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 68. Haleon Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 69. Haleon Topical NSAIDs Product Offered
Table 70. Haleon Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Haleon Main Business
Table 72. Haleon Latest Developments
Table 73. IBSA Pharma Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 74. IBSA Pharma Topical NSAIDs Product Offered
Table 75. IBSA Pharma Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. IBSA Pharma Main Business
Table 77. IBSA Pharma Latest Developments
Table 78. Hisamitsu Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 79. Hisamitsu Pharmaceutical Topical NSAIDs Product Offered
Table 80. Hisamitsu Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Hisamitsu Pharmaceutical Main Business
Table 82. Hisamitsu Pharmaceutical Latest Developments
Table 83. Daiichi Sankyo Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 84. Daiichi Sankyo Topical NSAIDs Product Offered
Table 85. Daiichi Sankyo Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Daiichi Sankyo Main Business
Table 87. Daiichi Sankyo Latest Developments
Table 88. Taisho Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 89. Taisho Pharmaceutical Topical NSAIDs Product Offered
Table 90. Taisho Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Taisho Pharmaceutical Main Business
Table 92. Taisho Pharmaceutical Latest Developments
Table 93. Perrigo Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 94. Perrigo Topical NSAIDs Product Offered
Table 95. Perrigo Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Perrigo Main Business
Table 97. Perrigo Latest Developments
Table 98. Viatris Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 99. Viatris Topical NSAIDs Product Offered
Table 100. Viatris Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Viatris Main Business
Table 102. Viatris Latest Developments
Table 103. Teva Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 104. Teva Pharmaceutical Topical NSAIDs Product Offered
Table 105. Teva Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Teva Pharmaceutical Main Business
Table 107. Teva Pharmaceutical Latest Developments
Table 108. Sun Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 109. Sun Pharmaceutical Topical NSAIDs Product Offered
Table 110. Sun Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Sun Pharmaceutical Main Business
Table 112. Sun Pharmaceutical Latest Developments
Table 113. Cipla Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 114. Cipla Topical NSAIDs Product Offered
Table 115. Cipla Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Cipla Main Business
Table 117. Cipla Latest Developments
Table 118. Mikasa Seiyaku Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 119. Mikasa Seiyaku Topical NSAIDs Product Offered
Table 120. Mikasa Seiyaku Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Mikasa Seiyaku Main Business
Table 122. Mikasa Seiyaku Latest Developments
Table 123. Kowa Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 124. Kowa Topical NSAIDs Product Offered
Table 125. Kowa Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Kowa Main Business
Table 127. Kowa Latest Developments
Table 128. Dr. Reddy’s Laboratories Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 129. Dr. Reddy’s Laboratories Topical NSAIDs Product Offered
Table 130. Dr. Reddy’s Laboratories Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Dr. Reddy’s Laboratories Main Business
Table 132. Dr. Reddy’s Laboratories Latest Developments
Table 133. Taro Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 134. Taro Pharmaceutical Topical NSAIDs Product Offered
Table 135. Taro Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Taro Pharmaceutical Main Business
Table 137. Taro Pharmaceutical Latest Developments
Table 138. Nichiban Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 139. Nichiban Topical NSAIDs Product Offered
Table 140. Nichiban Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Nichiban Main Business
Table 142. Nichiban Latest Developments
Table 143. Yuhan Corporation Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 144. Yuhan Corporation Topical NSAIDs Product Offered
Table 145. Yuhan Corporation Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Yuhan Corporation Main Business
Table 147. Yuhan Corporation Latest Developments
Table 148. Dong-A Socio Holdings Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 149. Dong-A Socio Holdings Topical NSAIDs Product Offered
Table 150. Dong-A Socio Holdings Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Dong-A Socio Holdings Main Business
Table 152. Dong-A Socio Holdings Latest Developments
Table 153. Almirall Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 154. Almirall Topical NSAIDs Product Offered
Table 155. Almirall Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. Almirall Main Business
Table 157. Almirall Latest Developments
Table 158. Searchlight Pharma Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 159. Searchlight Pharma Topical NSAIDs Product Offered
Table 160. Searchlight Pharma Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 161. Searchlight Pharma Main Business
Table 162. Searchlight Pharma Latest Developments
Table 163. Teikoku Pharma Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 164. Teikoku Pharma Topical NSAIDs Product Offered
Table 165. Teikoku Pharma Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 166. Teikoku Pharma Main Business
Table 167. Teikoku Pharma Latest Developments
Table 168. Hunan Jiudian Pharmaceutical Details, Company Type, Topical NSAIDs Area Served and Its Competitors
Table 169. Hunan Jiudian Pharmaceutical Topical NSAIDs Product Offered
Table 170. Hunan Jiudian Pharmaceutical Topical NSAIDs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 171. Hunan Jiudian Pharmaceutical Main Business
Table 172. Hunan Jiudian Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Topical NSAIDs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Topical NSAIDs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Topical NSAIDs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Topical NSAIDs Sales Market Share by Country/Region (2025)
Figure 8. Topical NSAIDs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Topical NSAIDs Market Size Market Share by Type in 2025
Figure 10. Global Topical NSAIDs Market Size Market Share by Active Pharmaceutical Ingredient in 2025
Figure 11. Global Topical NSAIDs Market Size Market Share by Prescription Status in 2025
Figure 12. Global Topical NSAIDs Market Size Market Share by Sales Channels in 2025
Figure 13. Topical NSAIDs in Osteoarthritis Pain
Figure 14. Global Topical NSAIDs Market: Osteoarthritis Pain (2021-2026) & ($ millions)
Figure 15. Topical NSAIDs in Back & Muscle Pain
Figure 16. Global Topical NSAIDs Market: Back & Muscle Pain (2021-2026) & ($ millions)
Figure 17. Topical NSAIDs in Sports Injury
Figure 18. Global Topical NSAIDs Market: Sports Injury (2021-2026) & ($ millions)
Figure 19. Topical NSAIDs in Others
Figure 20. Global Topical NSAIDs Market: Others (2021-2026) & ($ millions)
Figure 21. Global Topical NSAIDs Market Size Market Share by Application in 2025
Figure 22. Global Topical NSAIDs Revenue Market Share by Player in 2025
Figure 23. Global Topical NSAIDs Market Size Market Share by Region (2021-2026)
Figure 24. Americas Topical NSAIDs Market Size 2021-2026 ($ millions)
Figure 25. APAC Topical NSAIDs Market Size 2021-2026 ($ millions)
Figure 26. Europe Topical NSAIDs Market Size 2021-2026 ($ millions)
Figure 27. Middle East & Africa Topical NSAIDs Market Size 2021-2026 ($ millions)
Figure 28. Americas Topical NSAIDs Value Market Share by Country in 2025
Figure 29. United States Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 30. Canada Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 31. Mexico Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 32. Brazil Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 33. APAC Topical NSAIDs Market Size Market Share by Region in 2025
Figure 34. APAC Topical NSAIDs Market Size Market Share by Type (2021-2026)
Figure 35. APAC Topical NSAIDs Market Size Market Share by Application (2021-2026)
Figure 36. China Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 37. Japan Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 38. South Korea Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 39. Southeast Asia Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 40. India Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 41. Australia Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 42. Europe Topical NSAIDs Market Size Market Share by Country in 2025
Figure 43. Europe Topical NSAIDs Market Size Market Share by Type (2021-2026)
Figure 44. Europe Topical NSAIDs Market Size Market Share by Application (2021-2026)
Figure 45. Germany Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 46. France Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 47. UK Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 48. Italy Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 49. Russia Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 50. Middle East & Africa Topical NSAIDs Market Size Market Share by Region (2021-2026)
Figure 51. Middle East & Africa Topical NSAIDs Market Size Market Share by Type (2021-2026)
Figure 52. Middle East & Africa Topical NSAIDs Market Size Market Share by Application (2021-2026)
Figure 53. Egypt Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 54. South Africa Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 55. Israel Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 56. Turkey Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 57. GCC Countries Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 58. Americas Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 59. APAC Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 60. Europe Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 61. Middle East & Africa Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 62. United States Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 63. Canada Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 64. Mexico Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 65. Brazil Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 66. China Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 67. Japan Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 68. Korea Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 69. Southeast Asia Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 70. India Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 71. Australia Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 72. Germany Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 73. France Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 74. UK Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 75. Italy Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 76. Russia Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 77. Egypt Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 78. South Africa Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 79. Israel Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 80. Turkey Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 81. Global Topical NSAIDs Market Size Market Share Forecast by Type (2027-2032)
Figure 82. Global Topical NSAIDs Market Size Market Share Forecast by Application (2027-2032)
Figure 83. GCC Countries Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 1. Topical NSAIDs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Topical NSAIDs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Topical NSAIDs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Topical NSAIDs Sales Market Share by Country/Region (2025)
Figure 8. Topical NSAIDs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Topical NSAIDs Market Size Market Share by Type in 2025
Figure 10. Global Topical NSAIDs Market Size Market Share by Active Pharmaceutical Ingredient in 2025
Figure 11. Global Topical NSAIDs Market Size Market Share by Prescription Status in 2025
Figure 12. Global Topical NSAIDs Market Size Market Share by Sales Channels in 2025
Figure 13. Topical NSAIDs in Osteoarthritis Pain
Figure 14. Global Topical NSAIDs Market: Osteoarthritis Pain (2021-2026) & ($ millions)
Figure 15. Topical NSAIDs in Back & Muscle Pain
Figure 16. Global Topical NSAIDs Market: Back & Muscle Pain (2021-2026) & ($ millions)
Figure 17. Topical NSAIDs in Sports Injury
Figure 18. Global Topical NSAIDs Market: Sports Injury (2021-2026) & ($ millions)
Figure 19. Topical NSAIDs in Others
Figure 20. Global Topical NSAIDs Market: Others (2021-2026) & ($ millions)
Figure 21. Global Topical NSAIDs Market Size Market Share by Application in 2025
Figure 22. Global Topical NSAIDs Revenue Market Share by Player in 2025
Figure 23. Global Topical NSAIDs Market Size Market Share by Region (2021-2026)
Figure 24. Americas Topical NSAIDs Market Size 2021-2026 ($ millions)
Figure 25. APAC Topical NSAIDs Market Size 2021-2026 ($ millions)
Figure 26. Europe Topical NSAIDs Market Size 2021-2026 ($ millions)
Figure 27. Middle East & Africa Topical NSAIDs Market Size 2021-2026 ($ millions)
Figure 28. Americas Topical NSAIDs Value Market Share by Country in 2025
Figure 29. United States Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 30. Canada Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 31. Mexico Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 32. Brazil Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 33. APAC Topical NSAIDs Market Size Market Share by Region in 2025
Figure 34. APAC Topical NSAIDs Market Size Market Share by Type (2021-2026)
Figure 35. APAC Topical NSAIDs Market Size Market Share by Application (2021-2026)
Figure 36. China Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 37. Japan Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 38. South Korea Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 39. Southeast Asia Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 40. India Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 41. Australia Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 42. Europe Topical NSAIDs Market Size Market Share by Country in 2025
Figure 43. Europe Topical NSAIDs Market Size Market Share by Type (2021-2026)
Figure 44. Europe Topical NSAIDs Market Size Market Share by Application (2021-2026)
Figure 45. Germany Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 46. France Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 47. UK Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 48. Italy Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 49. Russia Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 50. Middle East & Africa Topical NSAIDs Market Size Market Share by Region (2021-2026)
Figure 51. Middle East & Africa Topical NSAIDs Market Size Market Share by Type (2021-2026)
Figure 52. Middle East & Africa Topical NSAIDs Market Size Market Share by Application (2021-2026)
Figure 53. Egypt Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 54. South Africa Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 55. Israel Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 56. Turkey Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 57. GCC Countries Topical NSAIDs Market Size Growth 2021-2026 ($ millions)
Figure 58. Americas Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 59. APAC Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 60. Europe Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 61. Middle East & Africa Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 62. United States Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 63. Canada Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 64. Mexico Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 65. Brazil Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 66. China Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 67. Japan Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 68. Korea Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 69. Southeast Asia Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 70. India Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 71. Australia Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 72. Germany Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 73. France Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 74. UK Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 75. Italy Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 76. Russia Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 77. Egypt Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 78. South Africa Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 79. Israel Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 80. Turkey Topical NSAIDs Market Size 2027-2032 ($ millions)
Figure 81. Global Topical NSAIDs Market Size Market Share Forecast by Type (2027-2032)
Figure 82. Global Topical NSAIDs Market Size Market Share Forecast by Application (2027-2032)
Figure 83. GCC Countries Topical NSAIDs Market Size 2027-2032 ($ millions)
